Cenra Inc. (TPE:3716)
Taiwan · Delayed Price · Currency is TWD 33.75
-0.20 (-0.59%)
At close: Jan 20, 2026
Cenra Market Cap
Cenra has a market cap or net worth of 4.95 billion as of January 22, 2026. Its market cap has decreased by -7.76% in one year.
Market Cap
4.95B
Enterprise Value
7.33B
Revenue
8.68B
Ranking
n/a
PE Ratio
12.76
Stock Price
33.75
Market Cap Chart
Since September 2, 2024, Cenra's market cap has decreased from 6.21B to 4.95B, a decrease of -20.24%. That is a compound annual growth rate of -15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 4.95B | 1.35% |
| Dec 31, 2025 | 4.88B | -12.15% |
| Dec 31, 2024 | 5.56B | -10.42% |
| Sep 2, 2024 | 6.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.65B |
| PharmaEssentia | 215.25B |
| Lotus Pharmaceutical | 82.58B |
| Heron Neutron Medical | 69.72B |
| BIONET | 5.48B |
| Panion & Bf Biotech | 5.46B |
| UnicoCell Biomed | 5.25B |
| HCmed Innovations | 4.86B |